ARCUTIS BIOTHERAPEUTICS INC (ARQT) Earnings History & Surprises
NASDAQ:ARQT • US03969K1088
24.59 USD
-0.23 (-0.93%)
At close: Mar 10, 2026
24.59 USD
0 (0%)
After Hours: 3/10/2026, 8:06:35 PM
Past quarterly earnings results for ARCUTIS BIOTHERAPEUTICS INC (ARQT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.02
Revenue Estimate103.29M
Last Reported
Release DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported$0.13
EPS Surprise 12.39%
Revenue Surprise 12.30%
Beat Rate
100%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.13 | 0.12 | 12.39% | 244.44% | 129.503M | 115.32M | 12.30% | 81.48% |
| Q3 2025 | 0.06 | -0.10 | 158.91% | 118.18% | 99.219M | 88.718M | 11.84% | 121.69% |
| Q2 2025 | -0.13 | -0.16 | 19.41% | 69.05% | 81.504M | 75.162M | 8.44% | 164.13% |
| Q1 2025 | -0.20 | -0.21 | 6.63% | 37.50% | 65.846M | 63.495M | 3.70% | 32.84% |
| Q4 2024 | -0.09 | -0.26 | 65.40% | 87.50% | 71.36M | 61.363M | 16.29% | 427.58% |
| Q3 2024 | -0.33 | -0.43 | 22.44% | 54.79% | 44.755M | 38.369M | 16.64% | 17.44% |
| Q2 2024 | -0.42 | -0.53 | 20.28% | 63.79% | 30.858M | 29.662M | 4.03% | 494.57% |
| Q1 2024 | -0.32 | -0.74 | 57.02% | 75.57% | 49.569M | 14.974M | 231.03% | 1,682.42% |
| Q4 2023 | -0.72 | -0.79 | 8.92% | 38.98% | 13.526M | 11.567M | 16.94% | 356.96% |
| Q3 2023 | -0.73 | -0.87 | 16.54% | 61.38% | 38.109M | 33.485M | 13.81% | 5,120.41% |
| Q2 2023 | -1.16 | -1.28 | 9.03% | 11.45% | 5.19M | 4.692M | 10.61% | - |
| Q1 2023 | -1.31 | -1.31 | 0.03% | -3.15% | 2.781M | 3.2M | -13.09% | - |
| Q4 2022 | -1.18 | -1.45 | 18.71% | 16.90% | 2.96M | 2.247M | 31.73% | - |
| Q3 2022 | -1.89 | -1.70 | -11.03% | -65.79% | 730K | 663K | 10.11% | - |
| Q2 2022 | -1.31 | -1.46 | 10.40% | -55.95% | - | - | ||
| Q1 2022 | -1.27 | -1.53 | 17.10% | -67.11% | - | - | ||
| Q4 2021 | -1.42 | -1.52 | 6.88% | -79.75% | - | - | ||
| Q3 2021 | -1.14 | -1.17 | 2.95% | -12.87% | - | - | ||
| Q2 2021 | -0.84 | -0.92 | 8.67% | 10.64% | - | - | ||
| Q1 2021 | -0.76 | -0.98 | 22.18% | 33.91% | - | - | ||
| Q4 2020 | -0.79 | -0.90 | 11.99% | - | - | - | ||
| Q3 2020 | -1.01 | -0.92 | -9.72% | - | - | - | ||
| Q2 2020 | -0.94 | -0.86 | -9.28% | - | - | - | ||
| Q1 2020 | -1.15 | -0.94 | -22.99% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
49.33%
Max EPS beat (4)
158.91%
Min EPS beat (4)
6.63%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
9.07%
Max Revenue beat (4)
12.30%
Min Revenue beat (4)
3.70%
Analysis
In the last 4 quarters, ARQT has consistently beaten EPS estimates in all releases
ARQT has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ARQT has beaten the EPS estimates by 49.3% on average.
In the last 4 quarters, ARQT has beaten the revenue estimates by 9.1% on average.
ARCUTIS BIOTHERAPEUTICS INC / ARQT Earnings FAQ
When did ARCUTIS BIOTHERAPEUTICS INC (ARQT) report earnings last quarter?
ARCUTIS BIOTHERAPEUTICS INC (ARQT) last reported earnings on 2/25/2026.
Did ARQT stock beat earnings estimates in the most recent quarter?
ARCUTIS BIOTHERAPEUTICS INC (ARQT) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ARQT stock beat earnings estimates?
In the last 4 quarters, ARCUTIS BIOTHERAPEUTICS INC (ARQT) has beaten EPS estimates in 4 out of 4 releases.